SCM
ALXO icon

Sterling Capital Management’s ALX Oncology ALXO Stock Holding History

Sterling Capital Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$785 Buy
+379
New +$678 ﹤0.01% 3173
2025
Q2 		– Sell
-34
Closed -$21 – 3271
2025
Q1 		$21 Hold
34
– – ﹤0.01% 3198
2024
Q4 		$57 Hold
34
– – ﹤0.01% 3206
2024
Q3 		$62 Buy
+34
New +$126 ﹤0.01% 3228

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Sterling Capital Management's ALXO Position: Q2 2026 in Review

Sterling Capital Management opened a new position in ALX Oncology (ALXO) in Q2 2026: 379 shares worth $785. The stake represents ﹤0.01% of the portfolio and ranks #3173 among its holdings. This is a return to the name: Sterling Capital Management previously reported a position in ALXO as recently as Q1 2025.

Sterling Capital Management first reported a position in ALXO in Q3 2024 and has held it in 4 quarters since. 94 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • Sterling Capital Management held 379 shares of ALX Oncology worth $785 as of Q2 2026.
  • ALX Oncology was a new Sterling Capital Management position in Q2 2026.
  • ALX Oncology made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3173 holding.
  • Sterling Capital Management first reported a position in ALX Oncology in Q3 2024 and has held it in 4 quarters since.
  • 94 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.